Omeros Corporation Skyrocketed

Omeros Corporation (OMER:NASDAQ) shot up at $10.42, a gain of 154.1%. On Wed, Oct 15, 2025, OMER:NASDAQ touched a New 2-Week High of $10.42. The stock got featured on our News Catalysts scanner on Wed, Oct 15, 2025 at 04:58 PM in the 'AGREEMENT' category. From Wed, Oct 01, 2025, the stock recorded 50.00% Up Days and 36.36% Green Days
About Omeros Corporation (OMER:NASDAQ)
Omeros Corp is a biopharmaceutical company. It focuses on research and development of small-molecule and protein therapeutics to treat inflammation, coagulopathies, and disorders of the central nervous system and sells Omidria for cataract surgeries.
Top 10 Gainers:
- Movella Holdings Inc. (MVLA:NASDAQ), 325%
- Genprex, Inc. (GNPX:NASDAQ), 232.67%
- Australian Oilseeds Holdings Limited (COOT:NASDAQ), 173.58%
- Omeros Corporation (OMER:NASDAQ), 154.15%
- Pinnacle Food Group Limited (PFAI:NASDAQ), 139.27%
- Theriva Biologics, Inc. (TOVX:NYSEMKT), 92.09%
- TrueCar, Inc. (TRUE:NASDAQ), 62.16%
- Soluna Holdings, Inc. (SLNH:NASDAQ), 53.76%
- Veritone, Inc. (VERI:NASDAQ), 53.66%
- Arcadia Biosciences, Inc. (RKDA:NASDAQ), 48.91%